Loading...
Valneva Earnings Reports
Nov 20, 2025
Valneva Q3 2025 Earnings Report
Estimated Revenue:$51M
+4.8% YoY
Estimated EPS:-$0.3
3.4% YoY
Aug 12, 2025
Valneva Q2 2025 Earnings Report
Estimated Revenue:$46.3M
+2.6% YoY
Estimated EPS:-$0.19
+36.7% YoY
May 16, 2025
Valneva Q1 2025 Earnings Report
Estimated Revenue:$40.2M
-44.2% YoY
Estimated EPS:-$0.2
121.3% YoY
Mar 19, 2025
Valneva Q4 2024 Earnings Report
Valneva posted €53 million in revenue for Q4 2024, but recorded a net loss of €36.9 million, impacted by higher R&D and finance expenses. Despite robust vaccine sales, profitability deteriorated from prior quarters.